All stock lists
Unlock the score
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
Healthcare · Biotechnology
1.64-0.08 (-4.65%)
Insider Score
/ 100
TENX Insider Score
TENAX THERAPEUTICS, INC. has a live Insider Score.
Scored on 4 qualifying trades from 3 insiders in the last 90 days.
TENX analyst forecast
TENX analyst consensus
Hold6 ratings
Buy 2 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TENX 12-month price target
No published price targets in the last 12 months.
Best analysts covering TENX
- Guggenheim0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TENX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-08-31 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-11 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2026-08-11 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-11 |
| — | Chardan Capital | Neutral | — | — | Downgraded | 2026-08-11 |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-08-10 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2026-07-31 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-07-29 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2026-07-02 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-06-24 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-06-22 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-12 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-16 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-12-17 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-08-14 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-02-20 |
| — | Roth MKM | Buy | — | — | Reiterated | 2023-11-13 |
| — | Ladenburg Thalmann | Buy | — | — | Upgraded | 2017-05-18 |
TENX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-10 | -1.26 | -0.38 | $0 | $0 |
| 2026-05-12 | -0.40 | -0.35 | $0 | $0 |
| 2026-07-31 | -0.38 | -0.35 | $0 | $0 |
| 2026-11-11 | -0.35 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.